SCHEMBL791652

SCHEMBL791652

Cc1cc(=O)ccn1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31748497 0.76
SCHEMBL20517132 0.73
SCHEMBL31748286 0.70 NPSR1 (0.37)
SCHEMBL24506333 0.70 POLB (0.34)
SCHEMBL21776576 0.69 MCL1 (0.39)
SCHEMBL31055636 0.69 HDAC6 (0.37)
SCHEMBL27293556 0.67 TOP2A (0.36)
SCHEMBL9526242 0.67 COMT (0.49)
SCHEMBL31055652 0.67 GAA (0.41)
SCHEMBL9526222 0.67 PCSK9 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388543-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-12-25 US claimed
EP-3777979-B1 ANTI-INFLAMMATORY COMPOUND AND PREPARATION AND USE THEREOF E NITIATE BIOPHARMACEUTICALS HANGZHOU CO LTD (CN) 2024-01-17 EP claimed
US-11440886-B2 Anti-inflammatory compound, and preparation and use thereof E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. (CN) 2022-09-13 US claimed
EP-1931758-A2 STAIN REMOVAL Unilever Plc (GB) 2008-06-18 EP claimed
CN-1317268-C 2,6-dimethylpyridine preparation method UNIV ZHEJIANG TECHNOLOGY (CN) 2007-05-23 CN claimed
WO-2007042140-A2 STAIN REMOVAL UNILEVER PLC (GB) 2007-04-19 WO claimed
CN-1733729-A 2,6-dimethylpyridine preparation method UNIV ZHEJIANG TECHNOLOGY (CN) 2006-02-15 CN claimed
US-20260048025-A1 COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES NATURAL EXTRACTION SYS LLC (US) 2026-02-19 US disclosed
US-20250388543-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-12-25 US disclosed
US-20250388541-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-12-25 US disclosed
US-12409152-B2 Compositions and methods related to dissolved oxides Natural Extraction Systems, LLC (US) 2025-09-09 US disclosed
EP-3777979-B1 ANTI-INFLAMMATORY COMPOUND AND PREPARATION AND USE THEREOF E NITIATE BIOPHARMACEUTICALS HANGZHOU CO LTD (CN) 2024-01-17 EP disclosed
CN-110407741-B Anti-inflammatory compound and preparation and application thereof 启元生物(杭州)有限公司 2023-03-21 CN disclosed
WO-2006084210-A9 HIF MODULATING COMPOUNDS AND METHODS OF USE THEREOF UNIV CALIFORNIA SAN DIEGO (US) 2006-10-26 WO disclosed
WO-2006084210-A2 HIF MODULATING COMPOUNDS AND METHODS OF USE THEREOF REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO (US) 2006-08-10 WO disclosed
CN-1736986-A Polyhydroxy stilbenes compound preparation and uses as drugs for suppressing SARS UNIV DALIAN TECH (CN) 2006-02-22 CN disclosed
CN-1733729-A 2,6-dimethylpyridine preparation method UNIV ZHEJIANG TECHNOLOGY (CN) 2006-02-15 CN disclosed
CN-1032648-C Process for preparation of platelet activating factor antagonist FIZER LTD (GB) 1996-08-28 CN disclosed
CN-1055925-A Pyridine derivate and preparation method thereof ICI PLC (GB) 1991-11-06 CN disclosed
CN-1032439-A A kind of preparation method of platelet-activating factor antagonist PFIZER LTD (GB) 1989-04-19 CN disclosed